Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Pickhardt

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|March 15, 2013
Progress and developments in tau aggregation inhibitors for Alzheimer diseaseBruno Bulic, Marcus Pickhardt, Eckhard Mandelkow
Neurobiology of Aging|February 15, 2011
"Lest we forget you--methylene blue..."R Heiner Schirmer, Heike Adler, Marcus Pickhardt, et al.
Neuropharmacology|February 13, 2010
Tau protein and tau aggregation inhibitorsBruno Bulic, Marcus Pickhardt, Eva-Maria Mandelkow, et al.
Current Alzheimer Research|February 4, 2017
Inhibition of Tau Protein Aggregation by Rhodanine-based Compounds Solubilized Via Specific Formulation Additives to Improve Bioavailability and Cell ViabilityMarcus Pickhardt, Carmen Lawatscheck, Hans G Borner, et al.
Current Alzheimer Research|July 14, 2007
Screening for inhibitors of tau protein aggregation into Alzheimer paired helical filaments: a ligand based approach results in successful scaffold hoppingGregor Larbig, Marcus Pickhardt, David G Lloyd, et al.
Angewandte Chemie (International Ed. in English)|February 13, 2013
Mechanistic basis of phenothiazine-driven inhibition of Tau aggregationElias Akoury, Marcus Pickhardt, Michal Gajda, et al.
Angewandte Chemie (International Ed. in English)|June 11, 2016
Generalizing the Concept of Specific Compound Formulation Additives towards Non-Fluorescent Drugs: A Solubilization Study on Potential Anti-Alzheimer-Active Small-Molecule CompoundsCarmen Lawatscheck, Marcus Pickhardt, Sebastian Wieczorek, et al.
Current Alzheimer Research|January 29, 2008
Inhibition of tau aggregation in cell models of tauopathyInna Khlistunova, Marcus Pickhardt, Jacek Biernat, et al.
Angewandte Chemie (International Ed. in English)|February 4, 2009
Development of tau aggregation inhibitors for Alzheimer's diseaseBruno Bulic, Marcus Pickhardt, Boris Schmidt, et al.
Angewandte Chemie (International Ed. in English)|November 7, 2007
Rhodanine-based tau aggregation inhibitors in cell models of tauopathyBruno Bulic, Marcus Pickhardt, Inna Khlistunova, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|March 15, 2013
Progress and developments in tau aggregation inhibitors for Alzheimer diseaseBruno Bulic, Marcus Pickhardt, Eckhard Mandelkow
Neurobiology of Aging|February 15, 2011
"Lest we forget you--methylene blue..."R Heiner Schirmer, Heike Adler, Marcus Pickhardt, et al.
Neuropharmacology|February 13, 2010
Tau protein and tau aggregation inhibitorsBruno Bulic, Marcus Pickhardt, Eva-Maria Mandelkow, et al.
Current Alzheimer Research|February 4, 2017
Inhibition of Tau Protein Aggregation by Rhodanine-based Compounds Solubilized Via Specific Formulation Additives to Improve Bioavailability and Cell ViabilityMarcus Pickhardt, Carmen Lawatscheck, Hans G Borner, et al.
Current Alzheimer Research|July 14, 2007
Screening for inhibitors of tau protein aggregation into Alzheimer paired helical filaments: a ligand based approach results in successful scaffold hoppingGregor Larbig, Marcus Pickhardt, David G Lloyd, et al.
Angewandte Chemie (International Ed. in English)|February 13, 2013
Mechanistic basis of phenothiazine-driven inhibition of Tau aggregationElias Akoury, Marcus Pickhardt, Michal Gajda, et al.
Angewandte Chemie (International Ed. in English)|June 11, 2016
Generalizing the Concept of Specific Compound Formulation Additives towards Non-Fluorescent Drugs: A Solubilization Study on Potential Anti-Alzheimer-Active Small-Molecule CompoundsCarmen Lawatscheck, Marcus Pickhardt, Sebastian Wieczorek, et al.
Current Alzheimer Research|January 29, 2008
Inhibition of tau aggregation in cell models of tauopathyInna Khlistunova, Marcus Pickhardt, Jacek Biernat, et al.
Angewandte Chemie (International Ed. in English)|February 4, 2009
Development of tau aggregation inhibitors for Alzheimer's diseaseBruno Bulic, Marcus Pickhardt, Boris Schmidt, et al.
Angewandte Chemie (International Ed. in English)|November 7, 2007
Rhodanine-based tau aggregation inhibitors in cell models of tauopathyBruno Bulic, Marcus Pickhardt, Inna Khlistunova, et al.
Pageof 3